1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. GERON CORP.
Geron Corp. XNAS: GERN

Geron Corp. Live Stock Price Today, Share Analysis and Chart

Weak Stock
about

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of...

Read More
1.10 -0.04 (-3.51%)
New 52W Low today
8.8M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Geron Corp. is on 08 Aug 2025 for the purpose of Geron Corp Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
15.8 / 100
Momentum Score
Technically Bearish
19.0 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
3
1Yr Price target upside is 208%
9 analysts

7

S

18

W

1

O

3

T

SWOT Analysis

Geron Corp. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..